What is the efficacy of the Watchman device for atrial fibrillation and discontinuation of anticoagulation?

The Watchman device effectively reduces stroke risk in atrial fibrillation patients unable to use long-term anticoagulation, with evidence supporting its use in minimizing bleeding risks. However, patient selection and individual risk assessments remain crucial.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24290404
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What is the efficacy of the Watchman device for atrial fibrillation and discontinuation of anticoagulation?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Atrial Fibrillation Management and Outcomes
article

What is the efficacy of the Watchman device for atrial fibrillation and discontinuation of anticoagulation?

Tripdatabase
article en

Abstract

The Watchman device effectively reduces stroke risk in atrial fibrillation patients unable to use long-term anticoagulation, with evidence supporting its use in minimizing bleeding risks. However, patient selection and individual risk assessments remain crucial.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon